Cover
Cover - shares | 6 Months Ended | |
Jun. 30, 2024 | Aug. 07, 2024 | |
Cover [Abstract] | ||
Document Type | 10-Q | |
Document Quarterly Report | true | |
Current Fiscal Year End Date | --12-31 | |
Document Period End Date | Jun. 30, 2024 | |
Document Transition Report | false | |
Entity File Number | 001-36063 | |
Entity Registrant Name | Altisource Asset Management Corporation | |
Entity Incorporation, State or Country Code | VI | |
Entity Tax Identification Number | 66-0783125 | |
Entity Address, Address Line One | 5100 Tamarind Reef | |
Entity Address, City or Town | Christiansted | |
Entity Address, Country | VI | |
Entity Address, Postal Zip Code | 00820 | |
City Area Code | 704 | |
Local Phone Number | 275-9113 | |
Title of 12(b) Security | Common stock, par value $0.01 per share | |
Trading Symbol | AAMC | |
Security Exchange Name | NYSEAMER | |
Entity Current Reporting Status | Yes | |
Entity Interactive Data Current | Yes | |
Entity Filer Category | Non-accelerated Filer | |
Entity Small Business | true | |
Entity Emerging Growth Company | false | |
Entity Shell Company | false | |
Entity Common Stock, Shares Outstanding | 2,554,512 | |
Entity Central Index Key | 0001555074 | |
Document Fiscal Year Focus | 2024 | |
Document Fiscal Period Focus | Q2 | |
Amendment Flag | false |
Condensed Consolidated Balance
Condensed Consolidated Balance Sheets (Unaudited) - USD ($) $ in Thousands | Jun. 30, 2024 | Dec. 31, 2023 |
Assets [Abstract] | ||
Loans held for sale, at fair value | $ 56 | $ 4,456 |
Loans held for investment, at fair value | 4,031 | 5,633 |
Cash and cash equivalents | 8,104 | 8,713 |
Other assets | 5,726 | 6,737 |
Total assets | 17,917 | 25,539 |
Liabilities | ||
Accrued expenses and other liabilities | 4,918 | 6,270 |
Lease liabilities | 364 | 900 |
Notes payable, including accrued paid-in-kind interest | 11,543 | 0 |
Total liabilities | 16,825 | 7,170 |
Commitment and contingencies (Note 4) | 0 | 0 |
Redeemable preferred stock: | ||
Preferred stock, $0.01 par value, 250,000 shares authorized as of June 30, 2024 and December 31, 2023. No shares were issued and outstanding as of June 30, 2024. 144,212 shares were issued and outstanding and had a $144,212 redemption value as of December 31, 2023. | 0 | 144,212 |
Stockholders' equity (deficit) | ||
Common stock, $0.01 par value, 5,000,000 authorized shares; 4,684,485 and 2,554,512 shares issued and outstanding, respectively, as of June 30, 2024 and December 31, 2023. | 46 | 46 |
Additional paid-in capital | 281,372 | 149,160 |
Retained earnings | 3,694 | 8,970 |
Accumulated other comprehensive income | 13 | 14 |
Treasury stock, at cost, 2,129,973 shares as of June 30, 2024 and December 31, 2023. | (284,033) | (284,033) |
Total stockholders' equity (deficit) | 1,092 | (125,843) |
Total liabilities, redeemable preferred stock and stock holders' equity | $ 17,917 | $ 25,539 |
Condensed Consolidated Balanc_2
Condensed Consolidated Balance Sheets (Unaudited) (Parenthetical) - USD ($) | Jun. 30, 2024 | Dec. 31, 2023 |
Statement of Financial Position [Abstract] | ||
Temporary equity, par or stated value (in per share) | $ 0.01 | $ 0.01 |
Temporary equity, authorized (in shares) | 250,000 | 250,000 |
Temporary equity, issued (in shares) | 0 | 144,212 |
Temporary equity, shares outstanding (in shares) | 0 | 144,212 |
Temporary equity, redemption amount | $ 144,212 | |
Common stock, par value (in USD per share) | $ 0.01 | $ 0.01 |
Common stock, shares authorized (in shares) | 5,000,000 | 5,000,000 |
Common stock, shares issued (in shares) | 4,684,485 | 2,554,512 |
Common stock, shares outstanding (in shares) | 4,684,485 | 2,554,512 |
Treasury stock, shares (in shares) | 2,129,973 | 2,129,973 |
Condensed Consolidated Statemen
Condensed Consolidated Statements of Operations (Unaudited) - USD ($) $ in Thousands | 3 Months Ended | 6 Months Ended | ||
Jun. 30, 2024 | Jun. 30, 2023 | Jun. 30, 2024 | Jun. 30, 2023 | |
Revenues [Abstract] | ||||
Loan interest income | $ 34 | $ 1,610 | $ 262 | $ 3,646 |
Loan fee income | 8 | 300 | 14 | 385 |
Realized gains on loans held for sale, net | 0 | 10 | 0 | 20 |
Total revenues | 42 | 1,920 | 276 | 4,051 |
Expenses: | ||||
Salaries and employee benefits | 270 | 1,909 | 494 | 3,773 |
Legal fees | 31 | 936 | 82 | 1,377 |
Professional fees | 332 | 608 | 698 | 1,088 |
General and administrative | 199 | 984 | 540 | 1,918 |
Servicing and asset management expense | 212 | 228 | 297 | 411 |
Interest expense | 292 | 872 | 543 | 1,954 |
Direct loan expense | 0 | 189 | 7 | 452 |
Loan sales and marketing expense | 0 | 382 | 0 | 791 |
Electric vehicle intellectual property development | 965 | 0 | 2,891 | 0 |
Total expenses | 2,301 | 6,108 | 5,552 | 11,764 |
Other income (expense) | ||||
Change in fair value of loans | 38 | 390 | (31) | 1,239 |
Realized losses on loans held for investment, net | 0 | 0 | 0 | (275) |
Other | 54 | 0 | 16 | (2) |
Total other income (expense) | 92 | 390 | (15) | 962 |
Net loss before income tax | (2,167) | (3,798) | (5,291) | (6,751) |
Income tax (benefit) expense | (1) | 16 | (15) | 51 |
Net loss | (2,166) | (3,814) | (5,276) | (6,802) |
Earnings per share | ||||
Net loss | (2,166) | (3,814) | (5,276) | (6,802) |
Gain of preferred stock transaction | 0 | 0 | 132,212 | 0 |
Numerator for earnings per share | $ (2,166) | $ (3,814) | $ 126,936 | $ (6,802) |
(Loss) income per share of common stock - Basic: | ||||
(Loss) income per basic common share (in USD per share) | $ (0.85) | $ (1.27) | $ 49.69 | $ (2.26) |
Weighted average common stock outstanding – basic (in shares) | 2,554,512 | 3,000,895 | 2,554,512 | 3,011,011 |
(Loss) income per share of common stock - Diluted: | ||||
(Loss) income per diluted common share (usd per share) | $ (0.85) | $ (1.27) | $ 49.28 | $ (2.26) |
Weighted average common stock outstanding – diluted (in shares) | 2,554,512 | 3,000,895 | 2,576,056 | 3,011,011 |
Condensed Consolidated Statem_2
Condensed Consolidated Statements of Comprehensive Loss (Unaudited) - USD ($) $ in Thousands | 3 Months Ended | 6 Months Ended | ||
Jun. 30, 2024 | Jun. 30, 2023 | Jun. 30, 2024 | Jun. 30, 2023 | |
Statement of Comprehensive Income [Abstract] | ||||
Net loss | $ (2,166) | $ (3,814) | $ (5,276) | $ (6,802) |
Other comprehensive income (loss): | ||||
Currency translation adjustments, net | 0 | 1 | (1) | 1 |
Total other comprehensive income (loss) | 0 | 1 | (1) | 1 |
Comprehensive loss | $ (2,166) | $ (3,813) | $ (5,277) | $ (6,801) |
Condensed Consolidated Statem_3
Condensed Consolidated Statements of Stockholders' Equity (Deficit) (Unaudited) - USD ($) $ in Thousands | Total | Preferred Stock | Common Stock | Additional Paid-in Capital | Retained Earnings | Accumulated Other Comprehensive Income (Loss) | Treasury Stock |
Beginning balance at Dec. 31, 2022 | $ 144,212 | ||||||
Balance, end of period at Mar. 31, 2023 | 144,212 | ||||||
Beginning balance (in shares) at Dec. 31, 2022 | 3,432,294 | ||||||
Beginning balance at Dec. 31, 2022 | $ (89,890) | $ 34 | $ 149,010 | $ 41,516 | $ 20 | $ (280,470) | |
Increase (Decrease) in Stockholders' Equity [Roll Forward] | |||||||
Adjustment for stock dividend (in shares) | 1,230,893 | ||||||
Adjustment for stock dividend | 0 | $ 12 | (12) | ||||
Common shares issued under share-based compensation plans, net of shares withheld for employee taxes (in shares) | 2,000 | ||||||
Treasury shares repurchased | (1,504) | (1,504) | |||||
Share-based compensation, net of tax | 160 | 160 | |||||
Net loss | (2,988) | (2,988) | |||||
Ending balance (in shares) at Mar. 31, 2023 | 4,665,187 | ||||||
Ending balance at Mar. 31, 2023 | (94,222) | $ 46 | 149,158 | 38,528 | 20 | (281,974) | |
Beginning balance at Dec. 31, 2022 | 144,212 | ||||||
Balance, end of period at Jun. 30, 2023 | 144,212 | ||||||
Beginning balance (in shares) at Dec. 31, 2022 | 3,432,294 | ||||||
Beginning balance at Dec. 31, 2022 | (89,890) | $ 34 | 149,010 | 41,516 | 20 | (280,470) | |
Increase (Decrease) in Stockholders' Equity [Roll Forward] | |||||||
Currency translation adjustments, net | 1 | ||||||
Net loss | (6,802) | ||||||
Ending balance (in shares) at Jun. 30, 2023 | 4,678,720 | ||||||
Ending balance at Jun. 30, 2023 | (98,176) | $ 46 | 149,252 | 34,714 | 21 | (282,209) | |
Beginning balance at Mar. 31, 2023 | 144,212 | ||||||
Balance, end of period at Jun. 30, 2023 | 144,212 | ||||||
Beginning balance (in shares) at Mar. 31, 2023 | 4,665,187 | ||||||
Beginning balance at Mar. 31, 2023 | (94,222) | $ 46 | 149,158 | 38,528 | 20 | (281,974) | |
Increase (Decrease) in Stockholders' Equity [Roll Forward] | |||||||
Adjustment for stock dividend (in shares) | 4,366 | ||||||
Common shares issued under share-based compensation plans, net of shares withheld for employee taxes (in shares) | 9,167 | ||||||
Common shares issued under share-based compensation plans, net of shares withheld for employee taxes | (235) | (235) | |||||
Share-based compensation, net of tax | 94 | 94 | |||||
Currency translation adjustments, net | 1 | 1 | |||||
Net loss | (3,814) | (3,814) | |||||
Ending balance (in shares) at Jun. 30, 2023 | 4,678,720 | ||||||
Ending balance at Jun. 30, 2023 | (98,176) | $ 46 | 149,252 | 34,714 | 21 | (282,209) | |
Beginning balance at Dec. 31, 2023 | $ 144,212 | 144,212 | |||||
Increase (Decrease) in Temporary Equity [Roll Forward] | |||||||
Preferred stock conversion | (144,212) | ||||||
Balance, end of period at Mar. 31, 2024 | 0 | ||||||
Beginning balance (in shares) at Dec. 31, 2023 | 2,554,512 | 4,684,485 | |||||
Beginning balance at Dec. 31, 2023 | $ (125,843) | $ 46 | 149,160 | 8,970 | 14 | (284,033) | |
Increase (Decrease) in Stockholders' Equity [Roll Forward] | |||||||
Currency translation adjustments, net | (1) | (1) | |||||
Preferred stock conversion | 132,212 | 132,212 | |||||
Net loss | (3,110) | (3,110) | |||||
Ending balance (in shares) at Mar. 31, 2024 | 4,684,485 | ||||||
Ending balance at Mar. 31, 2024 | 3,258 | $ 46 | 281,372 | 5,860 | 13 | (284,033) | |
Beginning balance at Dec. 31, 2023 | 144,212 | 144,212 | |||||
Balance, end of period at Jun. 30, 2024 | $ 0 | 0 | |||||
Beginning balance (in shares) at Dec. 31, 2023 | 2,554,512 | 4,684,485 | |||||
Beginning balance at Dec. 31, 2023 | $ (125,843) | $ 46 | 149,160 | 8,970 | 14 | (284,033) | |
Increase (Decrease) in Stockholders' Equity [Roll Forward] | |||||||
Currency translation adjustments, net | (1) | ||||||
Net loss | $ (5,276) | ||||||
Ending balance (in shares) at Jun. 30, 2024 | 4,684,485 | 4,684,485 | |||||
Ending balance at Jun. 30, 2024 | $ 1,092 | $ 46 | 281,372 | 3,694 | 13 | (284,033) | |
Beginning balance at Mar. 31, 2024 | 0 | ||||||
Balance, end of period at Jun. 30, 2024 | 0 | $ 0 | |||||
Beginning balance (in shares) at Mar. 31, 2024 | 4,684,485 | ||||||
Beginning balance at Mar. 31, 2024 | 3,258 | $ 46 | 281,372 | 5,860 | 13 | (284,033) | |
Increase (Decrease) in Stockholders' Equity [Roll Forward] | |||||||
Currency translation adjustments, net | 0 | ||||||
Net loss | $ (2,166) | (2,166) | |||||
Ending balance (in shares) at Jun. 30, 2024 | 4,684,485 | 4,684,485 | |||||
Ending balance at Jun. 30, 2024 | $ 1,092 | $ 46 | $ 281,372 | $ 3,694 | $ 13 | $ (284,033) |
Condensed Consolidated Statem_4
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($) $ in Thousands | 6 Months Ended | |
Jun. 30, 2024 | Jun. 30, 2023 | |
Operating activities: | ||
Net loss | $ (5,276) | $ (6,802) |
Adjustments to reconcile net loss to net cash used in operating activities | ||
Depreciation and amortization | 21 | 128 |
Share-based compensation | 0 | 254 |
Amortization of operating lease right-of-use assets | 516 | 193 |
Change in fair value of loans | 31 | (1,239) |
Net realized loss on sale of loans held for investment | 0 | 275 |
Net realized gain on sale of held for sale loans | 0 | (20) |
Loss on discarded assets | 89 | 0 |
Paid-in-Kind Interest | 543 | 0 |
Amortization of deferred financing fees | 0 | 63 |
Changes in operating assets and liabilities: | ||
Originations of held for sale loans | 0 | (10,592) |
Additional fundings of held for sale loans | (1,052) | (3,379) |
Proceeds from sales of held for sale loans | 0 | 3,687 |
Principal payments on held for sale loans | 5,356 | 491 |
Interest receivable | 99 | 638 |
Prepaid expenses and other assets | 380 | (487) |
Accounts payable and other accrued liabilities | (1,348) | (1,507) |
Other liabilities and operating lease liabilities | (536) | (186) |
Net cash used in operating activities | (1,177) | (18,483) |
Investing activities: | ||
Additional fundings of loans held for investment | (27) | (5,323) |
Proceeds from sales of loans held for investment | 0 | 6,346 |
Principal payments on loans held for investment | 1,595 | 30,306 |
Investment in property and equipment | 0 | (690) |
Net cash provided by investing activities | 1,568 | 30,639 |
Financing activities | ||
Conversion of preferred stock | (1,000) | 0 |
Proceeds from borrowed funds | 0 | 51,611 |
Repayment of borrowed funds | 0 | (60,273) |
Proceeds and payment of tax withholding on exercise of stock options, net | 0 | (235) |
Repurchase of common stock | 0 | (1,504) |
Net cash used in financing activities | (1,000) | (10,401) |
Net (decrease) increase in cash and cash equivalents | (609) | 1,755 |
Effect of exchange rate changes on cash and cash equivalents | 0 | 5 |
Consolidated cash, cash equivalents, and restricted cash, beginning of period | 8,713 | 12,774 |
Consolidated cash, cash equivalents, and restricted cash, end of period | 8,104 | 14,534 |
Reconciliation of Cash, Cash Equivalents and Restricted Cash | ||
Cash and cash equivalents | 8,104 | 10,532 |
Restricted cash | 0 | 4,002 |
Total cash, cash equivalents, and restricted cash | 8,104 | 14,534 |
Supplemental disclosure of cash information: | ||
Cash paid for interest | 0 | 1,404 |
Cash paid for income taxes | $ 0 | $ 65 |
Organization and Basis of Prese
Organization and Basis of Presentation | 6 Months Ended |
Jun. 30, 2024 | |
Organization, Consolidation and Presentation of Financial Statements [Abstract] | |
Organization and Basis of Presentation | 1. Organization and Basis of Presentation Altisource Asset Management Corporation (“we,” “our,” “us,” “AAMC,” or the “Company”) was incorporated in the United States Virgin Islands (“USVI”) on March 15, 2012 (our "inception"), and we commenced operations as an asset manager on December 21, 2012. During 2022 and 2023, the Company generated alternative private credit loans through Direct to Borrower Lending, Wholesale Originations and Correspondent Loan Acquisitions and funded the originated or acquired alternative loans from a combination of Company equity and lines of credit through its alternative lending group (“ALG”) business line. Those loans were then sold through forward commitments and repurchase contracts. Following a full year of ALG’s operations, our Board of Directors mandated a comprehensive review of the Company’s mortgage platform to improve the performance of the business. The review involved assessments of operational efficiency and capacity issues, opportunities for cost reductions, strategies for improving liquidity, among other initiatives, all with a view toward enhancing financial performance. While the Company has the ability to originate and purchase loans in the future, it does not anticipate doing so other than on a very selective basis. On October 6, 2023, the Company signed a non-exclusive patent and technology licensing agreement (“the PTL Agreement”) with System73 Limited (“System 73”), an entity controlled and managed by the 53.6% owners of the Company’s common stock. Under the PTL Agreement, the Company obtained a non-exclusive license for a set of patents for a control system which seeks to optimize the efficiency of electric vehicles (“EVs”). The Company’s investment in the EV business and the development of those business assets is currently the principal line of business of the Company. As consideration for the patent rights granted in the PTL Agreement, the Company has agreed to pay 6.2 million pounds sterling (approximately $8.0 million) in budgeted increments as they are incurred by System73 under a commercialization contract executed with Seabird Technologies Limited (“Seabird”), plus any future third-party expenses reasonably incurred in connection with the filing, prosecution and maintenance of the patents. Under the commercialization contract, Seabird has been engaged by System 73 to build a technology demonstrator to validate the functionality of an integrated drive unit using the technology and to develop a commercialization strategy for the technology, including the development of a sales pipeline, over an 18-month period commencing on January 1, 2024. Through June 30, 2024, AAMC has made payments of approximately $2.9 million in the aggregate toward these contractual obligations. Under the terms of the commercialization contract, Seabird will be the exclusive distributor of the control system for two years following development and will earn 10% of revenue from sales directly attributable to their efforts up to $250 million per annum; 20% of revenue from sales directly attributable to their efforts over $250 million per annum; and 10% ownership in System 73 (or any potential future owner of the control system at that time) when revenue attributable to their efforts exceeds $500 million per annum. In addition, the PTL Agreement contemplates certain equity incentives for System73 based on performance. The PTL Agreement sets out “AAMC Common Stock Milestones”, defined as each instance where the average closing price of the Company’s common stock for the preceding twenty (20) day period reaches an amount equal to or in excess of a multiple of $100 (i.e., $100, $200, $300, etc.). Upon the occurrence of each such AAMC Common Stock Milestone, System 73 would be awarded the number of shares of AAMC Common Stock equal to ten percent (10%) of the AAMC fully diluted Shares. Consistent with New York Stock Exchange rules, any equity award under the PTL Agreement will be subject to stockholder approval. The Company accounts for the equity award contract under the PTL Agreement as a derivative that is marked-to-market at the end of each reporting period. The Company determined that the equity award contract has a de minimis value as of June 30, 2024 and December 31, 2023 given the likelihood of achieving an AAMC Common Stock Milestone is remote based on the information available to management at those dates. AAMC, at its option, may terminate the PTL Agreement by providing System73 written notice of intent to terminate at any time and for any reason. Upon termination, in addition to all other obligations under the PTL Agreement, System73 shall promptly pay to AAMC an amount equal to the value of all payments made by AAMC pursuant to the agreement, plus a twenty percent (20%) annualized return on investment on such payments. We have no current plans to terminate the PTL Agreement as of June 30, 2024. Basis of presentation and use of estimates The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States (“U.S. GAAP”). All wholly owned subsidiaries are included, and all intercompany accounts and transactions have been eliminated. In management's opinion, the unaudited interim condensed consolidated financial statements contain all adjustments (all of which are normal and recurring in nature) considered necessary for a fair presentation of our financial position, results of operations and cash flows for the interim periods. The interim results are not necessarily indicative of results for a full year. We have omitted certain notes and other information from the interim condensed consolidated financial statements presented in this Quarterly Report on Form 10-Q as permitted by SEC rules and regulations. These condensed consolidated financial statements should be read in conjunction with our annual consolidated financial statements included within our Annual Report on Form 10-K for the year ended December 31, 2023. Liquidity As of June 30, 2024, the Company has unrestricted cash and cash equivalents of $8.1 million. The Company generated net losses of $2.2 million and $5.3 million for the three- and six-month periods ended June 30, 2024, respectively, and incurred operating cash outflows of $1.2 million for the six-month period ended June 30, 2024. While management believes that the cash on hand and future collection of outstanding loans receivable will provide sufficient liquidity to enable the Company to meet its obligations due within the next year, including its future commitments under the PTL Agreement, there is risk that the Company will need to seek additional sources of capital to continue its operations and to fulfill is longer-term obligations, including its notes payable that mature in 2027 and thereafter, especially if the Company is unable to realize future benefits from the PTL Agreement. The Company is actively managing its expenses and has reduced costs to conserve cash. The interim financial statements do not include any adjustments relating to the recoverability of recorded asset amounts or the amounts of liabilities that might be necessary should the Company be unable to continue as a going concern for a reasonable period of time. Use of estimates The preparation of condensed consolidated financial statements in conformity with U.S. GAAP requires us to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities as of the date of the condensed consolidated financial statements and the reported amounts of revenues and expenses during the reporting periods. Actual results could differ from those estimates. Loans held for sale or investment, carried at fair market value Through our ALG business line, we previously originated and purchased alternative loans. These loans are either classified as held for investment or held for sale depending upon the determination of management. We have elected to measure these alternative loans at fair value on a loan by loan basis. This option is available when we first recognize a financial asset. Subsequent changes in the fair value of these loans will be recorded in our Condensed Consolidated Statements of Operations in the period of the change. Purchased loans, also known as correspondent loans, can be bought with a net strip interest component in that the seller of the loan will receive an agreed upon percentage of the coupon interest generated from the sold loan. This strip component is reflected as service and asset management expense on the Condensed Consolidated Statements of Operations. A fair value measurement represents the price at which an orderly transaction would occur between willing market participants at the measurement date. We estimate the fair values of the loans held for investment or sale based on available inputs from the marketplace. The market for the loans that we hold at any given time is generally illiquid. Establishing fair values for illiquid assets is inherently subjective and is often dependent upon our estimates and modeling assumptions. In circumstances where relevant market inputs cannot be obtained, increased analysis and management judgment are required to estimate fair value. This generally requires us to establish internal assumptions about future cash flows and appropriate risk-adjusted discount rates. Regardless of the valuation inputs we apply, the objective of fair value measurement for assets is unchanged from what it would be if markets were operating at normal activity levels and/or transactions were orderly; that is, to determine the current exit price. When the Company sells a loan, a gain or loss will be recognized at the time of the sale in net income for the difference between the fair value and the book value. The fair value is measured as the agreed upon selling price from the contractual agreement with the buyer. See Note 2 - Loans Held for Sale or Investment at Fair Value for further discussion on fair value measurements. Interest for these loans is recognized as revenue based on the stated coupon when earned and deemed collectible or until a loan becomes more than 90 days past due, at which point the loan is placed on nonaccrual status and any accrued interest is reversed against interest income. When a seriously delinquent loan previously placed on nonaccrual status has been cured, meaning all delinquent principal and interest have been remitted by the borrower, the loan will be placed back on accrual status. Interest accrued as of period end is included within loans held for sale, at fair value or loans held for investment, at fair value in the Condensed Consolidated Balance Sheets as applicable. We evaluate transfers of loans held for sale or investment at fair value under the guidance in Financial Accounting Standards Board Accounting Standards Codification ("ASC") Topic No. 860, "Transfers and servicing of financial assets" ("ASC 860"), and account for such transfers as sales when three conditions in ASC 810-10-45-5 have been met. That is, we account for transfers of such financial assets as sales when the assets have been isolated from the Company, when the transferee has the right to pledge or exchanges the assets it receives and there are no restrictions on the transferee that constrain such right, and when the Company has no effective control over the transferred financial assets. There were no transfers of financial assets during the six months ended June 30, 2024. The Company realized an aggregate gain totaling $0.02 million and an aggregate loss of $0.28 million for the six months ended June 30, 2023 on loans held for sale and loans held for investment, respectively, which is included in realized gains on loans held for sale, net and realized losses on loans held for investment, net, respectively, in the accompanying Condensed Consolidated Statement of Operations. Each of the loans transferred during the six months ended June 30, 2023 qualified for sale accounting under ASC 860, as each of the loans was transferred to a third-party "as is" in exchange for cash, and the Company has no continuing involvement with the transferred financial assets or the transferees. Redeemable preferred stock Issuance of Series A Convertible Preferred Stock in 2014 Private Placement During the first quarter of 2014, we issued 250,000 shares of convertible preferred stock for $250.0 million to institutional investors. Under the Certificate of Designations of the Series A Shares (the “Certificate”), we had the option to redeem all of the Series A Shares on March 15, 2020 and on each successive five-year anniversary of March 15, 2020 thereafter. In connection with these same redemption dates, each holder of our Series A Shares had the right to give notice requesting us to redeem all of the Series A Shares held by such holder out of legally available funds. Under the terms of the Certificate, the Company would have been required to redeem if it had legally available funds to redeem all, but not less than all, of the Series A Shares requested by a holder to be redeemed on a redemption date. The redemption right would have been exercisable in connection with each redemption date every five years until the mandatory redemption date in 2044. The Series A Shares were not entitled to receive dividends. The Series A Shares were convertible into shares of our common stock at a conversion price of $1,250 per share (or an exchange rate of 0.8 shares of common stock for Series A Share), subject to certain anti-dilution adjustments. For a further description of other terms and conditions in respect of the Series A Shares, please refer to Note 1 - Organization and Basis of Presentation to the Consolidated Financial Statements included in our Annual Report on Form 10-K for the year ended December 31, 2023 and the Certificate of Designations for the Series A Convertible Preferred Stock referenced as Exhibit 3.3 in this Quarterly Report. Between January 31, 2020 and February 3, 2020, we received purported notices from all of the holders of our Series A Shares requesting us to redeem an aggregate of $250.0 million liquidation preference of our Series A Shares on March 15, 2020. We did not have legally available funds to redeem all, but not less than all, of the Series A Shares on March 15, 2020. As a result, we did not believe, under the terms of the Certificate, that we were obligated to redeem any of the Series A Shares under the Certificate. Related litigation – Luxor (plaintiff) v. AAMC (defendant) On February 3, 2020, a complaint was filed in New York state court by Luxor Capital Group LP and various related entities collectively “Luxor”), each a holder of AAMC Series A Shares, against AAMC claiming breach of contract, specific performance, unjust enrichment, and related damages and expenses. Luxor sought an order requiring AAMC to redeem its Series A Shares, damages of up to $150,000,000, as well as payment of its costs and expenses in the lawsuit. As noted below, pursuant to a settlement agreement entered into by the parties dated January 11, 2024, this litigation has been terminated and dismissed with prejudice. See “Settlement activities”. – AAMC (plaintiff) v. Nathaniel Redleaf (defendant) On October 31, 2022, AAMC filed suit in the Superior Court of the Virgin Islands (subsequently removed to federal court), against former Company director Nathaniel Redleaf alleging disclosure of confidential information to Luxor in breach of the fiduciary duty he owed to AAMC. AAMC sought a number of remedies, including compensatory damages and disgorgement of any benefit received by Luxor or Mr. Redleaf as a result of such alleged breaches. As noted below, all litigation with Mr. Redleaf and Luxor has been resolved and dismissed with prejudice. See “Settlement activities”. Settlement activities From February 2021 through July 2022, the Company entered into a series of settlement agreements with various institutional holders of the Series A Shares resulting in the redemption and cancellation thereof. For information concerning the terms and conditions of these settlements, see Note 1 - Organization and Basis of Presentation to the Consolidated Financial Statements included in our Annual Report on From 10-K for the year ended December 31, 2023. On January 11, 2024 (the “Effective Date”), AAMC entered into a settlement agreement with Luxor and Mr. Redleaf, pursuant to which the parties agreed as follows: • Luxor surrendered all 144,212 of its Series A Shares it held to AAMC. Luxor and AAMC agreed that their related Securities Purchase Agreement dated March 13, 2014, along with the Certificate, are void and all rights thereunder are extinguished. • The Company agreed to provide the following consideration to Luxor ▪ A $1,000,000 cash payment within five days of the Effective Date, plus ▪ Three Promissory Notes in the following principal amounts and durations: Year Principal Amount (Notes Payable) 2024 $ — 2025 — 2026 — 2027 2,000,000 2028 — Thereafter 9,000,000 • Each Note bears annual interest at either 7.5% on a cash basis or 10% paid-in-kind (“PIK”) basis, at the election of AAMC and the carrying amount of such notes approximates fair value as of June 30, 2024. The Company agreed to refrain from making common stock repurchases or issuing dividends at any time the PIK option is in effect and is subject to certain additional covenants enumerated in the Notes. • The Company also agreed to pay Luxor 50% of any proceeds received in respect of its damage claims in the action brought by Erbey Holding Corporation pending in USVI Superior Court with case number SX-2018-CV-146, up to a cumulative payout cap to Luxor of $50,000,000. • The parties agreed and stipulated to dismissal with prejudice of the following actions: (i) Luxor Capital Group LP, et. al v. Altisource Asset Management Corporation filed in the Supreme Court of the State of New York in the County of New York, with index number 650746/2020 (including Luxor’s withdrawal of its pending request for further appellate review by the New York Court of Appeals), and (ii) Altisource Asset Management Corporation v. Nathaniel Redleaf et. al pending in the United States District Court for the District of the Virgin Islands, with case number 1:23-cv-00002. The parties exchanged mutual releases of their respective claims relating to the aforesaid actions, SPA and Certificate, as applicable, and agreed that their settlement shall not constitute or be construed as an admission that any of the parties violated the law, breached any contract or committed any wrong whatsoever. Recently issued accounting standards For a discussion of our recently issued accounting standards, please see Note 1 - Organization and Basis of Presentation - “Recently issued accounting standards” in our Annual Report on Form 10-K for the year ended December 31, 2023. Recent Rules and Accounting Pronouncements In November 2023, the Financial Accounting Standards Board (FASB) issued Accounting Standards Update 2023-07, “Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures” (ASU 2023-07), which requires expanded disclosure of significant segment expense and other segment items on an annual and interim basis. ASU 2023-07 is effective for the Company for annual periods beginning after January 1, 2024 and interim periods beginning after January 1, 2025. The Company is currently evaluating the impact ASU 2023-07 will have on its financial statement disclosures. In March 2024, the Securities and Exchange Commission (the “SEC”) adopted the final rules that will require certain climate-related information in registration statements and annual reports. In April 2024, the SEC voluntarily stayed the new rules as a result of pending legal challenges. The new rules include a requirement to disclose material climate-related risks, descriptions of board oversight and risk management activities, the material impacts of these risks on a registrants’ strategy, business model and outlook, and any material climate-related targets or goals, as well as material effects of severe weather events and other natural conditions and greenhouse gas emissions. Prior to the stay in the new rules, they would have been effective for annual periods beginning January 1, 2025, except for the greenhouse gas emissions disclosure which would have been effective for annual periods beginning January 1, 2026. The Company is currently evaluating the impact of these rules on its disclosures. |
Loans Held for Sale or Investme
Loans Held for Sale or Investment at Fair Value | 6 Months Ended |
Jun. 30, 2024 | |
Fair Value Disclosures [Abstract] | |
Loans Held for Sale or Investment at Fair Value | 2. Loans Held for Sale or Investment at Fair Value Our loan portfolio consists of business purpose loans secured by single family, multifamily and commercial real estate that were acquired from third party originators or issued by us. The composition of the loan portfolio by classification as of June 30, 2024 and December 31, 2023, is summarized in the table below ($ in thousands): Held for Sale Held for Investment June 30, 2024 December 31, 2023 June 30, 2024 December 31, 2023 Total loan commitments $ 31 $ 7,420 $ 4,575 $ 6,235 Add/ (Less): construction holdbacks (1) 25 (2,988) (149) (214) Total principal outstanding 56 4,432 4,426 6,021 Change in fair value of loans — 24 (395) (388) Total loans at fair value $ 56 $ 4,456 $ 4,031 $ 5,633 (1) Construction holdbacks include in process accounts such as payments, advances, interest reserve, accrued interest and other accounts. The loan portfolio consists of 9 loans at June 30, 2024, with a weighted average coupon of 9.6%, of which the Company receives a net yield of 9.3% after taking into account the strip interest to the sellers of the loans. The weighted average life of the portfolio is approximately 0.9 years past maturity. One loan represents 71% of the total principal outstanding at June 30, 2024. There were six loans on nonaccrual status or 90 days or more past due at June 30, 2024, with a fair value of $4.6 million. These loans have an unpaid principal balance of $4.4 million at June 30, 2024. As of June 30, 2024, we have commenced formal foreclosure proceedings on six loans with an aggregate fair value of $4.0 million in order to force the sale of the real estate that serves as collateral for such loans. We expect that the sale of the collateral will allow us to recover the full repayment of the outstanding loans and accrued interest as of June 30, 2024. The table below represents activity within the loan portfolio by classification for the period shown ($ in thousands): Loans Held for Sale Loans Held for Investment Balance at December 31, 2023 $ 4,456 $ 5,633 Additional fundings 1,052 27 Interest receivable (72) (27) Payoffs and repayments (5,356) (1,595) Fair value adjustment (24) (7) Balance at June 30, 2024 $ 56 $ 4,031 The composition of the total loan commitment by state as of June 30, 2024 is summarized below ($ in thousands): State Commitment Percent of Portfolio Florida 3,279 71.2 % Arkansas 553 12.0 % Texas 350 7.6 % Michigan 229 5.0 % Pennsylvania 176 3.8 % Georgia 14 0.3 % Other 5 0.1 % Total $ 4,606 100.0 % For financial reporting purposes of our alternative loans, we follow a fair value hierarchy established under GAAP that is used to determine the fair value of financial instruments. This hierarchy prioritizes relevant market inputs in order to determine an “exit price” at the measurement date, or at the price at which an asset could be sold or a liability could be transferred in an orderly process that is not a forced liquidation or distressed sale. In certain cases, inputs used to measure fair value fall into different levels of the fair value hierarchy. In such cases, the level at which the fair value measurement falls is determined based on the lowest level input that is significant to the fair value measurement. Our assessment of the significance of a particular input requires judgment and considers factors specific to the asset or liability being measured. The following table presents the assets that are reported at fair value on a recurring basis as of June 30, 2024 and December 31, 2023, as well as the fair value of hierarchy of the valuation inputs used to measure fair value. We did not have any liabilities to report at fair value on a recurring basis as of June 30, 2024 and December 31, 2023. Assets Carrying Fair Value Measurements Using (In thousands) Value Level 1 Level 2 Level 3 June 30, 2024 Loans held for sale $ 56 $ — $ — $ 56 Loans held for investment 4,031 — — 4,031 Total measured $ 4,087 $ — $ — $ 4,087 December 31, 2023 Loans held for sale $ 4,456 $ — $ — $ 4,456 Loans held for investment 5,633 — — 5,633 Total measured $ 10,089 $ — $ — $ 10,089 The estimated fair value for our business purpose loans is determined using the discounted cash flow model (“DCF”) to estimate the net present value of the future cash flows expected from each loan. For performing loans, the DCF is based on the future expected cash flows of each loan in accordance with its contractual terms net of the strip component. Cash flows for performing loans with construction holdbacks incorporate the draws to complete the required improvements to the underlying property securing the loan. For nonaccrual loans, the estimated cash flows are based on the current fair value of the collateral of the loans, in which the Company will utilize a third-party appraisal to determine the fair value (Level 3). On a loan-by-loan basis, the weighted average discount rate range utilized for the DCF applied to the net yield to be received by the Company was nil which is less than the overall yield on the portfolio of 9.3%, resulting in the increase in value of the portfolio at June 30, 2024. The determination of the discount rate was based on analysis of the current interest rates charged for business purpose loans in conjunction with the increase in rates for other underlying base rates such as the 10-year U.S. treasury bond and the 30 day Secured Overnight Financing Rate ("SOFR") (Level 3). For nonaccrual loans, the discount applied to the value of the collateral was based on available market information on REO sales transaction as of the valuation date (Level 3). We did not transfer any assets from one level to another level during the six months ended June 30, 2024 or 2023. We evaluate the change in fair value attributable to instrument-specific credit risk as the excess of the total change in fair value over the change in fair value attributable to changes in the risk-free rate. Instrument-specific credit risk had an immaterial impact on the change in fair value recognized for loans held during the six months ended June 30, 2024 and 2023. |
Leases
Leases | 6 Months Ended |
Jun. 30, 2024 | |
Leases [Abstract] | |
Leases | 3. Leases We currently lease office space under operating leases in Christiansted, St. Croix, U.S. Virgin Islands and Bengaluru, India. Effective April 2024, we have moved to a new office space in Bengaluru, India. Prior to the termination of the lease in October 2023, we also leased space in Tampa, Florida. On June 21, 2024, the Company provided written notice of termination to the landlord of the U.S. Virgin Islands lease due to multiple significant breaches of landlord obligations. As of June 30, 2024 and December 31, 2023, our weighted average remaining lease term, including applicable extensions, was 3.1 years and 3.3 years, respectively, and we applied a discount rate of 7.0% to our office leases. We determined the discount rate for each lease to be either the discount rate stated in the lease agreement or our estimated rate that we would charge to finance real estate assets. During the three and six months ended June 30, 2024, we recognized rent expense of $6,078 and $81,495, respectively. During the three and six months ended June 30, 2023, we recognized rent expense of $122,000 and $246,000, respectively, related to long-term operating leases. We had $288 short-term rent expense for the three and six months ended June 30, 2024; we had no short term rent expense for the three and six months ended June 30, 2023 . We include rent expense as a component of general and administrative expenses in the Condensed Consolidated Statements of Operations. We had no finance leases during the three and six months ended June 30, 2024 or 2023. The following table presents a maturity analysis of our operating leases as of June 30, 2024 ($ in thousands): Operating Lease Liabilities 2024 (1) $ 131 2025 131 2026 131 2027 11 Total lease payments 404 Less: interest 40 Lease liabilities $ 364 (1) Excludes the three and six months ended June 30, 2024 |
Commitments and Contingencies
Commitments and Contingencies | 6 Months Ended |
Jun. 30, 2024 | |
Commitments and Contingencies Disclosure [Abstract] | |
Commitments and Contingencies | 4. Commitments and Contingencies Litigation, claims and assessments Information regarding reportable legal proceedings is contained in the “Commitments and Contingencies” note in the financial statements provided in our Annual Report on Form 10-K for the year ended December 31, 2023. We establish reserves for specific legal proceedings when we determine that the likelihood of an outcome is probable and the amount of loss can be reasonably estimated. We do not currently have any reserves for our legal proceedings. The following updates and restates the description of the previously reported matters: Litigation regarding Luxor and Redleaf Please refer to Note 1 - Organization and Basis of Presentation – Sections “Related litigation” and “Settlement activities” . Arbitration regarding Indroneel Chatterjee, former Chief Executive Officer On May 3, 2021, the Company’s former CEO Indroneel Chatterjee commenced an arbitration against the Company and each of its directors. The arbitration complaint alleged that the Company’s termination of Mr. Chatterjee’s employment for cause was in breach of his employment agreement. The complaint also alleged certain extra-contractual claims against the Company. On October 19, 2022, following extensive briefing by the parties, the arbitrator dismissed all of Mr. Chatterjee's then remaining claims and granted summary judgment on one of the Company's counterclaims requiring Mr. Chatterjee to pay the Company $400,000 (the return of half of his initial signing bonus). On December 29, 2022, the arbitrator entered a final order which granted additional award of fees, costs and interest to the Company in the amount of over $1 million, bringing the Company's total judgment against Mr. Chatterjee to approximately $1.6 million. The Company has taken steps to attempt to enforce the judgment against Mr. Chatterjee and waives no rights or remedies with respect thereto. AAMC’s damage claims against Blackrock and PIMCO On April 12, 2018, an action was filed in the Superior Court of the Virgin Islands, Division of St. Croix under the caption Erbey Holding Corporation, et al. v. Blackrock Financial Management Inc., et al., case number SX-2018-CV-146. The action was initially filed by Plaintiffs Erbey Holding Corporation, John R. Erbey Family Limited Partnership, by its general partner Jupiter Capital, Inc., Salt Pond Holdings, LLC, Munus, L.P., Carisma Trust, by its trustee, Venia, LLC, and Tribue Limited Partnership (collectively, the “HoldCo Plaintiffs”). AAMC joined in the action as an additional named Plaintiff pursuant to Court order dated March 30, 2023. The action was filed against Defendants Blackrock Financial Management, Inc., Blackrock Investment Management, LLC, Blackrock Investments, LLC, Blackrock Capital Management, Inc., Blackrock, Inc, Pacific Investment Management Company LLC, PIMCO Investments, LLC and John and Jane Does 1-10. The complaint alleges that Defendants, aided by their agents and co-conspirators, engaged in an unlawful enterprise and conspiracy to harm Plaintiffs and related companies, including Ocwen Financial Corporation (“Ocwen”), by damaging their operations, business relationships and standing in the industry. As set out in the complaint, the alleged wrongful and malicious conduct of Defendants, which included fraudulent disparagement and targeted short-selling, constitutes common law intentional torts and violations of Section 605 of the Virgin Islands Criminally Influenced and Corrupt Organizations Act (“CICO”). AAMC and the HoldCo Plaintiffs seek compensatory damages in amounts reflecting the substantial diminution in value of their stock and stock holdings, respectively, and/or lost profits, plus lost future market value appreciation and profits. Any direct or indirect compensatory damages awarded under CICO are subject to automatic trebling. The action also seeks punitive damages of up to nine times any compensatory amounts based on the egregious nature of the alleged intentional torts, as well as an award of attorneys’ fees and other expenses incurred in prosecuting the case. Defendants filed multiple motions that sought to dismiss the case on various alleged grounds, including that Plaintiffs failed to adequately plead their respective statutory and common law tort claims and that the Court allegedly lacked personal jurisdiction over Defendants. On July 13, 2023, a court-appointed Staff Master issued a comprehensive recommendation that all of AAMC’s legal claims should be permitted to proceed and that the Court should exercise personal jurisdiction over four of the five named Blackrock-entity Defendants and both of the named PIMCO-entity Defendants. The Staff Master recommended that Blackrock, Inc. be dismissed for lack of personal jurisdiction. On December 4, 2023, the trial judge adopted the Staff Master’s recommendation and overruled Defendants’ objections thereto. The trial judge certified the findings of jurisdiction for a potential interlocutory discretionary appeal. The Virgin Islands Supreme Court has not yet determined whether or not to accept Defendants’ appeal. The trial judge also entered a final order dismissing Blackrock, Inc., thus permitting an appeal by Plaintiffs as of right to the Virgin Islands Supreme Court. Briefing in Plaintiff’s appeal concluded on April 17, 2024. On February 27, 2024, the trial judge denied Defendants’ request for a stay of discovery during the pendency of appellate matters before the Virgin Islands Supreme Court and directed the Staff Master to conduct a discovery conference on an expedited basis. The Staff Master held a discovery conference and on April 4, 2024, entered a Discovery and Scheduling Plan which provides for all discovery to be completed in the fall of 2025. Discovery is ongoing. |
Related-Party Transactions
Related-Party Transactions | 6 Months Ended |
Jun. 30, 2024 | |
Related Party Transactions [Abstract] | |
Related-Party Transactions | 5. Related Party Transactions On June 3, 2024, the Company, as lender, entered into a revolving loan agreement (the “Loan”) with Altisource Solutions Inc., (the “Borrower”), which is affiliated with a major shareholder of the Company. Under the terms of the revolving loan agreement, the Company will provide a revolving loan facility to the Borrower in an initial aggregate amount of up to $1,000,000 but not less than $250,000 and with the potential to be increased up to $3,000,000 in the aggregate as set forth in the Loan. The Loan bears interest at the rate of 12% per annum computed on the basis of a 365/366-day year; provided, however, that the Borrower and the Company may mutually agree to adjust the interest rate from time to time. No amounts were drawn on the Loan as of June 30, 2024. |
Incentive Compensation and Shar
Incentive Compensation and Share-Based Payments | 6 Months Ended |
Jun. 30, 2024 | |
Share-Based Payment Arrangement [Abstract] | |
Incentive Compensation and Share-Based Payments | 6. Incentive Compensation and Share-Based Payments 2012 Special Equity Incentive Plan A special grant of stock options and restricted stock was made to certain employees of Altisource Portfolio Solutions N.A. (“ASPS”) related to our separation from ASPS under the 2012 Special Equity Incentive Plan (the “2012 Special Plan”). We included no share-based compensation in our condensed consolidated financial statements for the portion of these grants made to ASPS employees. The shares of restricted stock became fully vested and were issued during 2017. Dividends received on restricted stock are forfeitable and are accumulated until the time of vesting at the same rate and on the same date as on shares of common stock. Upon the vesting of stock options and restricted stock, we may withhold up to the statutory minimum to satisfy the resulting employee tax obligation. Stock options We recorded no compensation expense related to grants of stock options for the three and six months ended June 30, 2024 and 2023. As of both June 30, 2024 and December 31, 2023, we had no outstanding options issued under all of our share-based compensation plans or as inducement awards. Restricted stock During the six months ended June 30, 2024 and the year ended December 31, 2023, we granted no shares of service-based restricted stock to members of management. We recorded no compensation expense related to our share-based compensation plan for the three and six months ended June 30, 2024. We recorded $0.1 million and $0.3 million of compensation expense related to our share-based compensation for the three and six months ended June 30, 2023, respectively. As of June 30, 2024 and December 31, 2023, we had an no unrecognized share-based compensation cost to be recognized. |
Income Taxes
Income Taxes | 6 Months Ended |
Jun. 30, 2024 | |
Income Tax Disclosure [Abstract] | |
Income Taxes | 7. Income Taxes We are domiciled in the USVI and are obligated to pay taxes to the USVI on our income. We applied for tax benefits from the USVI Economic Development Commission (“EDC”) and received our certificate of benefits (“the EDC Certificate”), effective as of February 1, 2013. Pursuant to the Certificate, so long as we comply with its provisions, we will receive a 90% tax reduction on our USVI-sourced income taxes until 2043. By letter dated April 13, 2023, the EDC approved an extension of the temporary full-time employment waiver (the “Waiver”) of the Company’s minimum employment requirements to five full-time USVI employees for the period from January 1, 2023 through June 30, 2023. By letter dated February 19, 2024, the EDC approved an additional extension for the period July 1, 2023 to December 31, 2024. At June 30, 2024, the Company met the minimum employment requirements required under the provisions of the Waiver. As of June 30, 2024 and December 31, 2023, we accrued no interest or penalties associated with any unrecognized tax benefits, nor did we recognize any interest expense or penalties during the six months ended June 30, 2024 and 2023. The Company recorded a $1,000 tax benefit and a book loss of $2.2 million for the second quarter of 2024. The material differences between the effective tax rate and the statutory tax rate are the EDC benefit discussed above and the fact that the USVI EDC is in a full valuation allowance position and incurred a current quarter loss. |
Earnings Per Share
Earnings Per Share | 6 Months Ended |
Jun. 30, 2024 | |
Earnings Per Share [Abstract] | |
Earnings Per Share | 8. Earnings Per Share The following table sets forth the components of basic and diluted (loss) income per share ($ in thousands, except share and per share amounts): Three months ended June 30, Six months ended June 30, 2024 2023 2024 2023 Numerator Net loss $ (2,166) $ (3,814) $ (5,276) $ (6,802) Gain of preferred stock transaction — — 132,212 — Numerator for earnings per share - net (loss) income attributable to common stockholders $ (2,166) $ (3,814) $ 126,936 $ (6,802) Denominator Weighted average common stock outstanding - basic 2,554,512 3,000,895 2,554,512 3,011,011 Weighted average common stock outstanding - diluted 2,554,512 3,000,895 2,576,056 3,011,011 (Loss) income per basic common share $ (0.85) $ (1.27) $ 49.69 $ (2.26) (Loss) income per diluted common share $ (0.85) $ (1.27) $ 49.28 $ (2.26) On September 8, 2023, the Company’s Board of Directors approved a 70% stock dividend. Each stockholder of record on September 18, 2023 received a dividend of seven tenths additional share of common stock for each then-held share, with any fractional shares rounded up, to be distributed after close of trading on October 31, 2023. The Company’s common stock began trading on a stock-adjusted basis on November 1, 2023. The par value of the Company’s common stock was not affected by the split and remained at $0.01 per share. The computations of basic and diluted EPS have been adjusted on a retrospective basis for all periods presented. We excluded the items presented below from the calculation of diluted (loss) income per share as they were antidilutive for the periods indicated, as the Company had a net loss from operations for each period presented ($ in thousands): Three months ended June 30, Six months ended June 30, 2024 2023 2024 2023 Denominator Restricted stock 14,571 47,563 — 48,615 Preferred stock, if converted — 115,370 — 115,370 |
Segment Information
Segment Information | 6 Months Ended |
Jun. 30, 2024 | |
Segment Reporting [Abstract] | |
Segment Information | 9. Segment Information The Company has two reportable segments: Loan Operations and Control System Commercialization. ALG is our primary business in the Loan Operations segment. Activity in the Control System Commercialization segment began during the first quarter of 2024 and is comprised entirely of electric vehicle intellectual property development expenses. The segment has no assets or liabilities at June 30, 2024. |
Subsequent Events
Subsequent Events | 6 Months Ended |
Jun. 30, 2024 | |
Subsequent Events [Abstract] | |
Subsequent Events | 10. Subsequent Events |
Pay vs Performance Disclosure
Pay vs Performance Disclosure - USD ($) $ in Thousands | 3 Months Ended | 6 Months Ended | ||||
Jun. 30, 2024 | Mar. 31, 2024 | Jun. 30, 2023 | Mar. 31, 2023 | Jun. 30, 2024 | Jun. 30, 2023 | |
Pay vs Performance Disclosure | ||||||
Net loss | $ (2,166) | $ (3,110) | $ (3,814) | $ (2,988) | $ (5,276) | $ (6,802) |
Insider Trading Arrangements
Insider Trading Arrangements | 3 Months Ended |
Jun. 30, 2024 | |
Trading Arrangements, by Individual | |
Rule 10b5-1 Arrangement Adopted | false |
Non-Rule 10b5-1 Arrangement Adopted | false |
Rule 10b5-1 Arrangement Terminated | false |
Non-Rule 10b5-1 Arrangement Terminated | false |
Organization and Basis of Pre_2
Organization and Basis of Presentation (Policies) | 6 Months Ended |
Jun. 30, 2024 | |
Organization, Consolidation and Presentation of Financial Statements [Abstract] | |
Basis of presentation | The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States (“U.S. GAAP”). All wholly owned subsidiaries are included, and all intercompany accounts and transactions have been eliminated. In management's opinion, the unaudited interim condensed consolidated financial statements contain all adjustments (all of which are normal and recurring in nature) considered necessary for a fair presentation of our financial position, results of operations and cash flows for the interim periods. The interim results are not necessarily indicative of results for a full year. We have omitted certain notes and other information from the interim condensed consolidated financial statements presented in this Quarterly Report on Form 10-Q as permitted by SEC rules and regulations. These condensed consolidated financial statements should be read in conjunction with our annual consolidated financial statements included within our Annual Report on Form 10-K for the year ended December 31, 2023. |
Use of estimates | The preparation of condensed consolidated financial statements in conformity with U.S. GAAP requires us to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities as of the date of the condensed consolidated financial statements and the reported amounts of revenues and expenses during the reporting periods. Actual results could differ from those estimates. |
Loans held for sale or investment, carried at fair market value | Through our ALG business line, we previously originated and purchased alternative loans. These loans are either classified as held for investment or held for sale depending upon the determination of management. We have elected to measure these alternative loans at fair value on a loan by loan basis. This option is available when we first recognize a financial asset. Subsequent changes in the fair value of these loans will be recorded in our Condensed Consolidated Statements of Operations in the period of the change. Purchased loans, also known as correspondent loans, can be bought with a net strip interest component in that the seller of the loan will receive an agreed upon percentage of the coupon interest generated from the sold loan. This strip component is reflected as service and asset management expense on the Condensed Consolidated Statements of Operations. A fair value measurement represents the price at which an orderly transaction would occur between willing market participants at the measurement date. We estimate the fair values of the loans held for investment or sale based on available inputs from the marketplace. The market for the loans that we hold at any given time is generally illiquid. Establishing fair values for illiquid assets is inherently subjective and is often dependent upon our estimates and modeling assumptions. In circumstances where relevant market inputs cannot be obtained, increased analysis and management judgment are required to estimate fair value. This generally requires us to establish internal assumptions about future cash flows and appropriate risk-adjusted discount rates. Regardless of the valuation inputs we apply, the objective of fair value measurement for assets is unchanged from what it would be if markets were operating at normal activity levels and/or transactions were orderly; that is, to determine the current exit price. When the Company sells a loan, a gain or loss will be recognized at the time of the sale in net income for the difference between the fair value and the book value. The fair value is measured as the agreed upon selling price from the contractual agreement with the buyer. See Note 2 - Loans Held for Sale or Investment at Fair Value for further discussion on fair value measurements. Interest for these loans is recognized as revenue based on the stated coupon when earned and deemed collectible or until a loan becomes more than 90 days past due, at which point the loan is placed on nonaccrual status and any accrued interest is reversed against interest income. When a seriously delinquent loan previously placed on nonaccrual status has been cured, meaning all delinquent principal and interest have been remitted by the borrower, the loan will be placed back on accrual status. Interest accrued as of period end is included within loans held for sale, at fair value or loans held for investment, at fair value in the Condensed Consolidated Balance Sheets as applicable. |
Recently issued accounting standards | Recently issued accounting standards For a discussion of our recently issued accounting standards, please see Note 1 - Organization and Basis of Presentation - “Recently issued accounting standards” in our Annual Report on Form 10-K for the year ended December 31, 2023. Recent Rules and Accounting Pronouncements In November 2023, the Financial Accounting Standards Board (FASB) issued Accounting Standards Update 2023-07, “Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures” (ASU 2023-07), which requires expanded disclosure of significant segment expense and other segment items on an annual and interim basis. ASU 2023-07 is effective for the Company for annual periods beginning after January 1, 2024 and interim periods beginning after January 1, 2025. The Company is currently evaluating the impact ASU 2023-07 will have on its financial statement disclosures. In March 2024, the Securities and Exchange Commission (the “SEC”) adopted the final rules that will require certain climate-related information in registration statements and annual reports. In April 2024, the SEC voluntarily stayed the new rules as a result of pending legal challenges. The new rules include a requirement to disclose material climate-related risks, descriptions of board oversight and risk management activities, the material impacts of these risks on a registrants’ strategy, business model and outlook, and any material climate-related targets or goals, as well as material effects of severe weather events and other natural conditions and greenhouse gas emissions. Prior to the stay in the new rules, they would have been effective for annual periods beginning January 1, 2025, except for the greenhouse gas emissions disclosure which would have been effective for annual periods beginning January 1, 2026. The Company is currently evaluating the impact of these rules on its disclosures. |
Organization and Basis of Pre_3
Organization and Basis of Presentation (Tables) | 6 Months Ended |
Jun. 30, 2024 | |
Organization, Consolidation and Presentation of Financial Statements [Abstract] | |
Schedule of Settlement Agreement | Year Principal Amount (Notes Payable) 2024 $ — 2025 — 2026 — 2027 2,000,000 2028 — Thereafter 9,000,000 |
Loans Held for Sale or Invest_2
Loans Held for Sale or Investment at Fair Value (Tables) | 6 Months Ended |
Jun. 30, 2024 | |
Fair Value Disclosures [Abstract] | |
Schedule of Accounts, Notes, Loans and Financing Receivable | The composition of the loan portfolio by classification as of June 30, 2024 and December 31, 2023, is summarized in the table below ($ in thousands): Held for Sale Held for Investment June 30, 2024 December 31, 2023 June 30, 2024 December 31, 2023 Total loan commitments $ 31 $ 7,420 $ 4,575 $ 6,235 Add/ (Less): construction holdbacks (1) 25 (2,988) (149) (214) Total principal outstanding 56 4,432 4,426 6,021 Change in fair value of loans — 24 (395) (388) Total loans at fair value $ 56 $ 4,456 $ 4,031 $ 5,633 (1) Construction holdbacks include in process accounts such as payments, advances, interest reserve, accrued interest and other accounts. The table below represents activity within the loan portfolio by classification for the period shown ($ in thousands): Loans Held for Sale Loans Held for Investment Balance at December 31, 2023 $ 4,456 $ 5,633 Additional fundings 1,052 27 Interest receivable (72) (27) Payoffs and repayments (5,356) (1,595) Fair value adjustment (24) (7) Balance at June 30, 2024 $ 56 $ 4,031 |
Schedule of Loan Commitment Classified by Geographic Areas | The composition of the total loan commitment by state as of June 30, 2024 is summarized below ($ in thousands): State Commitment Percent of Portfolio Florida 3,279 71.2 % Arkansas 553 12.0 % Texas 350 7.6 % Michigan 229 5.0 % Pennsylvania 176 3.8 % Georgia 14 0.3 % Other 5 0.1 % Total $ 4,606 100.0 % |
Schedule of Fair Value Measurements, Recurring and Nonrecurring | The following table presents the assets that are reported at fair value on a recurring basis as of June 30, 2024 and December 31, 2023, as well as the fair value of hierarchy of the valuation inputs used to measure fair value. We did not have any liabilities to report at fair value on a recurring basis as of June 30, 2024 and December 31, 2023. Assets Carrying Fair Value Measurements Using (In thousands) Value Level 1 Level 2 Level 3 June 30, 2024 Loans held for sale $ 56 $ — $ — $ 56 Loans held for investment 4,031 — — 4,031 Total measured $ 4,087 $ — $ — $ 4,087 December 31, 2023 Loans held for sale $ 4,456 $ — $ — $ 4,456 Loans held for investment 5,633 — — 5,633 Total measured $ 10,089 $ — $ — $ 10,089 |
Leases (Tables)
Leases (Tables) | 6 Months Ended |
Jun. 30, 2024 | |
Leases [Abstract] | |
Schedule of Maturity Analysis of Operating Leases | The following table presents a maturity analysis of our operating leases as of June 30, 2024 ($ in thousands): Operating Lease Liabilities 2024 (1) $ 131 2025 131 2026 131 2027 11 Total lease payments 404 Less: interest 40 Lease liabilities $ 364 (1) Excludes the three and six months ended June 30, 2024 |
Earnings Per Share (Tables)
Earnings Per Share (Tables) | 6 Months Ended |
Jun. 30, 2024 | |
Earnings Per Share [Abstract] | |
Schedule of Components of Basic and Diluted Income (Loss) Per Share | The following table sets forth the components of basic and diluted (loss) income per share ($ in thousands, except share and per share amounts): Three months ended June 30, Six months ended June 30, 2024 2023 2024 2023 Numerator Net loss $ (2,166) $ (3,814) $ (5,276) $ (6,802) Gain of preferred stock transaction — — 132,212 — Numerator for earnings per share - net (loss) income attributable to common stockholders $ (2,166) $ (3,814) $ 126,936 $ (6,802) Denominator Weighted average common stock outstanding - basic 2,554,512 3,000,895 2,554,512 3,011,011 Weighted average common stock outstanding - diluted 2,554,512 3,000,895 2,576,056 3,011,011 (Loss) income per basic common share $ (0.85) $ (1.27) $ 49.69 $ (2.26) (Loss) income per diluted common share $ (0.85) $ (1.27) $ 49.28 $ (2.26) |
Schedule of Antidilutive Securities Excluded From Computation of Income (Loss) Per Share | We excluded the items presented below from the calculation of diluted (loss) income per share as they were antidilutive for the periods indicated, as the Company had a net loss from operations for each period presented ($ in thousands): Three months ended June 30, Six months ended June 30, 2024 2023 2024 2023 Denominator Restricted stock 14,571 47,563 — 48,615 Preferred stock, if converted — 115,370 — 115,370 |
Organization and Basis of Pre_4
Organization and Basis of Presentation - Additional Information (Details) $ / shares in Units, £ in Millions | 3 Months Ended | 6 Months Ended | |||||||||
Jan. 11, 2024 USD ($) note shares | Oct. 06, 2023 USD ($) $ / shares | Feb. 03, 2020 USD ($) | Jun. 30, 2024 USD ($) shares | Jun. 30, 2023 USD ($) | Jun. 30, 2014 | Mar. 31, 2014 USD ($) $ / shares shares | Jun. 30, 2024 USD ($) shares | Jun. 30, 2023 USD ($) | Dec. 31, 2023 USD ($) shares | Oct. 06, 2023 GBP (£) | |
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items] | |||||||||||
Electric vehicle intellectual property development | $ 965,000 | $ 0 | $ 2,891,000 | $ 0 | |||||||
Cash and cash equivalents | 8,104,000 | 10,532,000 | 8,104,000 | 10,532,000 | $ 8,713,000 | ||||||
Net loss | $ 2,166,000 | 3,814,000 | 5,276,000 | 6,802,000 | |||||||
Net cash used in operating activities | $ 1,177,000 | 18,483,000 | |||||||||
Loans receivable, threshold period past due | 90 days | 90 days | |||||||||
Realized gains on loans held for sale, net | $ 0 | 10,000 | $ 0 | 20,000 | |||||||
Realized losses on loans held for investment, net | $ 0 | $ 0 | $ 0 | $ 275,000 | |||||||
Temporary equity, issued (in shares) | shares | 0 | 250,000 | 0 | 144,212 | |||||||
Temporary equity, stock issued during period | $ 250,000,000 | ||||||||||
Temporary equity, redemption period | 5 years | 5 years | |||||||||
Temporary equity, conversion price per share (in USD per share) | $ / shares | $ 1,250 | ||||||||||
Exchange ratio for preferred stock to common stock | 0.8 | ||||||||||
Luxor Capital Group, LP, et al. v. Altisource Asset Management Corporation | |||||||||||
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items] | |||||||||||
Settlement agreement, cash payment | $ 1,000,000 | ||||||||||
Loss contingency, damages awarded, number of business days to pay | 5 days | ||||||||||
Settlement agreement, number of promissory notes issued | note | 3 | ||||||||||
Settlement agreement, note issuance, interest rate on a cash basis | 7.50% | ||||||||||
Settlement agreement, note issuance, interest rate on a paid-in-kind basis | 10% | ||||||||||
Damages awarded, percentage of proceeds received in other case | 50% | ||||||||||
Litigation case, damages awarded, payout cap from other case | $ 50,000,000 | ||||||||||
Luxor | |||||||||||
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items] | |||||||||||
Damages sought | $ 150,000,000 | ||||||||||
Luxor | Luxor Capital Group, LP, et al. v. Altisource Asset Management Corporation | |||||||||||
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items] | |||||||||||
Settlement agreement, number of shares surrendered (in shares) | shares | 144,212 | ||||||||||
Series A Preferred Stock | |||||||||||
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items] | |||||||||||
Temporary equity, liquidation preference | $ 250,000,000 | ||||||||||
Patent and Technology Licensing Agreement | |||||||||||
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items] | |||||||||||
Electric vehicle intellectual property development | $ 2,900,000 | ||||||||||
System73 Limited | Patent and Technology Licensing Agreement | |||||||||||
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items] | |||||||||||
Licensing agreement, agreement with entity owned by common share holders, percentage of ownership | 53.60% | 53.60% | |||||||||
Licensing agreement, consideration | $ 8,000,000 | £ 6.2 | |||||||||
Licensing agreement, prototype creation, period | 18 months | ||||||||||
Number of years patented technology in development | 2 years | ||||||||||
Licensing agreement, partnership incentives, net sales efforts up to threshold, percentage of revenue earned | 10% | ||||||||||
Licensing agreement, partnership incentives, net sales efforts up to threshold | $ 250,000,000 | ||||||||||
Licensing agreement, partnership incentives, net sales efforts over threshold, percentage of revenue earned | 20% | ||||||||||
Licensing agreement, partnership incentives, net sales efforts over threshold | $ 250,000,000 | ||||||||||
Licensing agreement, partnership incentives, ownership entity who owns patents | 10% | ||||||||||
Licensing agreement, partnership incentives, annual revenue threshold | $ 500,000,000 | ||||||||||
Licensing agreement, equity incentives, common stock milestones, preceding period | 20 days | ||||||||||
Licensing agreement, equity incentives, common stock milestones, stock price multiple (in USD per share) | $ / shares | $ 100 | ||||||||||
Licensing agreement, equity incentives, common stock milestones, percentage of fully diluted shares awarded | 10% | ||||||||||
Licensing agreement, termination clause, annualized return on investment of total payments made | 20% |
Organization and Basis of Pre_5
Organization and Basis of Presentation - Schedule of Settlement Agreement (Details) - Luxor Capital Group, LP, et al. v. Altisource Asset Management Corporation | Jan. 11, 2024 USD ($) |
Note Issued Due and Payable on Current Year Anniversary of Effective Date | |
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items] | |
Settlement agreement, principal due | $ 0 |
Note Issued Due and Payable on First-year Anniversary of Effective Date | |
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items] | |
Settlement agreement, principal due | 0 |
Note Issued Due and Payable on Two-year Anniversary of Effective Date | |
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items] | |
Settlement agreement, principal due | 0 |
Note Issued Due and Payable on Three-year Anniversary of Effective Date | |
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items] | |
Settlement agreement, principal due | 2,000,000 |
Note Issued Due and Payable on Four-year Anniversary of Effective Date | |
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items] | |
Settlement agreement, principal due | 0 |
Note Issued Due and Payable on Five-year Anniversary of Effective Date | |
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items] | |
Settlement agreement, principal due | $ 9,000,000 |
Loans Held for Sale or Invest_3
Loans Held for Sale or Investment at Fair Value - Schedule of Accounts, Notes, Loans and Financing Receivable (Details) - USD ($) $ in Thousands | Jun. 30, 2024 | Dec. 31, 2023 |
Accounts, Notes, Loans and Financing Receivable [Line Items] | ||
Total loan commitments | $ 4,606 | |
Total loans at fair value | 4,031 | $ 5,633 |
Held for Sale | ||
Accounts, Notes, Loans and Financing Receivable [Line Items] | ||
Total loan commitments | 31 | 7,420 |
Add/ (Less): construction holdbacks | 25 | (2,988) |
Total principal outstanding | 56 | 4,432 |
Change in fair value of loans | 0 | 24 |
Total loans at fair value | 56 | 4,456 |
Held for Investment | ||
Accounts, Notes, Loans and Financing Receivable [Line Items] | ||
Total loan commitments | 4,575 | 6,235 |
Add/ (Less): construction holdbacks | (149) | (214) |
Total principal outstanding | 4,426 | 6,021 |
Change in fair value of loans | (395) | (388) |
Total loans at fair value | $ 4,031 | $ 5,633 |
Loans Held for Sale or Invest_4
Loans Held for Sale or Investment at Fair Value - Additional Information (Details) $ in Millions | 6 Months Ended |
Jun. 30, 2024 USD ($) loan | |
Fair Value, Concentration of Risk, Financial Statement Captions [Line Items] | |
Number of loan portfolio | 9 |
Weighted average coupon | 9.60% |
Net yield | 9.30% |
Weighted average life, terms | 10 months 24 days |
Number of loan outstanding | 1 |
Percentage of outstanding total principal amount | 71% |
Number of loans on nonaccrual status or 90 days or more past due | 6 |
Carry value of nonaccrual loan | $ | $ 4.6 |
Loans held for investment, unpaid principal balance | $ | $ 4.4 |
Number of loans formal foreclosure proceedings loans | 6 |
Aggregate fair value of loans investment for sale in foreclosure | $ | $ 4 |
Valuation Technique, Discounted Cash Flow | |
Fair Value, Concentration of Risk, Financial Statement Captions [Line Items] | |
Net yield | 0% |
Valuation Technique, Discounted Cash Flow | Portfolio Loans | |
Fair Value, Concentration of Risk, Financial Statement Captions [Line Items] | |
Net yield | 9.30% |
Loans Held for Sale or Invest_5
Loans Held for Sale or Investment at Fair Value - Schedule Of Accounts Loan Portfolio By Classification (Details) $ in Thousands | 6 Months Ended |
Jun. 30, 2024 USD ($) | |
Financing Receivable, Excluding Accrued Interest, Allowance for Credit Loss [Roll Forward] | |
Balance at December 31, 2023 | $ 5,633 |
Balance at June 30, 2024 | 4,031 |
Loans Held for Sale | |
Financing Receivable, Excluding Accrued Interest, Allowance for Credit Loss [Roll Forward] | |
Balance at December 31, 2023 | 4,456 |
Additional fundings | 1,052 |
Interest receivable | (72) |
Payoffs and repayments | (5,356) |
Fair value adjustment | (24) |
Balance at June 30, 2024 | 56 |
Loans Held for Investment | |
Financing Receivable, Excluding Accrued Interest, Allowance for Credit Loss [Roll Forward] | |
Balance at December 31, 2023 | 5,633 |
Additional fundings | 27 |
Interest receivable | (27) |
Payoffs and repayments | (1,595) |
Fair value adjustment | (7) |
Balance at June 30, 2024 | $ 4,031 |
Loans Held for Sale or Invest_6
Loans Held for Sale or Investment at Fair Value -Schedule of Loan Commitment Classified by Geographic Areas (Details) $ in Thousands | Jun. 30, 2024 USD ($) |
Fair Value, Investments, Entities that Calculate Net Asset Value Per Share [Line Items] | |
Commitment | $ 4,606 |
Percent of Portfolio | 100% |
Florida | |
Fair Value, Investments, Entities that Calculate Net Asset Value Per Share [Line Items] | |
Commitment | $ 3,279 |
Percent of Portfolio | 71.20% |
Arkansas | |
Fair Value, Investments, Entities that Calculate Net Asset Value Per Share [Line Items] | |
Commitment | $ 553 |
Percent of Portfolio | 12% |
Texas | |
Fair Value, Investments, Entities that Calculate Net Asset Value Per Share [Line Items] | |
Commitment | $ 350 |
Percent of Portfolio | 7.60% |
Michigan | |
Fair Value, Investments, Entities that Calculate Net Asset Value Per Share [Line Items] | |
Commitment | $ 229 |
Percent of Portfolio | 5% |
Pennsylvania | |
Fair Value, Investments, Entities that Calculate Net Asset Value Per Share [Line Items] | |
Commitment | $ 176 |
Percent of Portfolio | 3.80% |
Georgia | |
Fair Value, Investments, Entities that Calculate Net Asset Value Per Share [Line Items] | |
Commitment | $ 14 |
Percent of Portfolio | 0.30% |
Other | |
Fair Value, Investments, Entities that Calculate Net Asset Value Per Share [Line Items] | |
Commitment | $ 5 |
Percent of Portfolio | 0.10% |
Loans Held for Sale or Invest_7
Loans Held for Sale or Investment at Fair Value - Schedule of Fair Value Measurements, Recurring (Details) - USD ($) $ in Thousands | Jun. 30, 2024 | Dec. 31, 2023 |
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Loans held for sale | $ 56 | $ 4,456 |
Loans held for investment | 4,031 | 5,633 |
Fair Value Measurements, Recurring | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Loans held for sale | 56 | 4,456 |
Loans held for investment | 4,031 | 5,633 |
Total measured | 4,087 | 10,089 |
Fair Value Measurements, Recurring | Level 1 | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Loans held for sale | 0 | 0 |
Loans held for investment | 0 | 0 |
Total measured | 0 | 0 |
Fair Value Measurements, Recurring | Level 2 | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Loans held for sale | 0 | 0 |
Loans held for investment | 0 | 0 |
Total measured | 0 | 0 |
Fair Value Measurements, Recurring | Level 3 | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Loans held for sale | 56 | 4,456 |
Loans held for investment | 4,031 | 5,633 |
Total measured | $ 4,087 | $ 10,089 |
Leases - Additional Information
Leases - Additional Information (Details) - USD ($) | 3 Months Ended | 6 Months Ended | |||
Jun. 30, 2024 | Jun. 30, 2023 | Jun. 30, 2024 | Jun. 30, 2023 | Dec. 31, 2023 | |
Leases [Abstract] | |||||
Weighted average remaining lease term | 3 years 1 month 6 days | 3 years 1 month 6 days | 3 years 3 months 18 days | ||
Operating lease, discount rate | 7% | 7% | 7% | ||
Rent expense- long term lease | $ 6,078 | $ 122,000 | $ 81,495 | $ 246,000 | |
Rent expense- short term lease | $ 288 | $ 0 | $ 288 | $ 0 |
Leases - Schedule of Maturity A
Leases - Schedule of Maturity Analysis of Operating Leases (Details) - USD ($) $ in Thousands | Jun. 30, 2024 | Dec. 31, 2023 |
Operating Lease Liabilities | ||
2024 | $ 131 | |
2025 | 131 | |
2026 | 131 | |
2027 | 11 | |
Total lease payments | 404 | |
Less: interest | 40 | |
Lease liabilities | $ 364 | $ 900 |
Commitments and Contingencies -
Commitments and Contingencies - Litigation Settlement Additional Information (Details) - Former Chief Executive Officer, Indroneel Chatterjee $ in Thousands | 20 Months Ended | ||
Dec. 29, 2022 USD ($) | Oct. 19, 2022 USD ($) counterclaim | Dec. 29, 2022 USD ($) | |
Loss Contingencies [Line Items] | |||
Number of counterclaims with a granted summary judgement | counterclaim | 1 | ||
Amount awarded to company | $ | $ 1,000 | $ 400 | $ 1,600 |
Commitments and Contingencies_2
Commitments and Contingencies - Gain Contingency Additional Information (Details) - Erbey Holding Corporation et al. v. Blackrock Management Inc., et al. - Positive Outcome of Litigation | Jun. 30, 2024 USD ($) | Dec. 31, 2023 USD ($) | Jul. 13, 2023 defendant | Mar. 30, 2023 |
Gain Contingencies [Line Items] | ||||
Compensatory amounts multiplier of alleged intentional torts | 9 | |||
Number of defendants the court should exercise personal jurisdiction over | 4 | |||
Number of defendants | 5 | |||
Gain contingency | $ | $ 0 | $ 0 |
Related Party Transactions (Det
Related Party Transactions (Details) - The Revolving Loan Agreement - Affiliated entity - Altisource Solutions Inc. - Revolving Credit Facility - Altisource Asset Management - USD ($) | 1 Months Ended | |
Jun. 30, 2024 | Jun. 03, 2024 | |
Related party transaction [Line Items] | ||
Maximum borrowing capacity | $ 1,000,000 | |
Minimum borrowing capacity | 250,000 | |
Maximum borrowing capacity, including accordion feature | $ 3,000,000 | |
Amounts drawn on loan facility | $ 0 | |
Line of Credit | ||
Related party transaction [Line Items] | ||
Stated interest rate | 12% |
Incentive Compensation and Sh_2
Incentive Compensation and Share-Based Payments (Details) - USD ($) | 3 Months Ended | 6 Months Ended | 12 Months Ended | ||
Jun. 30, 2024 | Jun. 30, 2023 | Jun. 30, 2024 | Jun. 30, 2023 | Dec. 31, 2023 | |
Share-based compensation arrangement by share-based payment award [Line Items] | |||||
Share-based compensation | $ 0 | $ 0 | $ 0 | $ 0 | |
Stock options outstanding (in shares) | 0 | 0 | 0 | ||
Number of shares granted (in shares) | 0 | 0 | |||
Restricted stock | |||||
Share-based compensation arrangement by share-based payment award [Line Items] | |||||
Share-based compensation | $ 0 | $ 100,000 | $ 0 | $ 300,000 | |
Unrecognized stock compensation | $ 0 | $ 0 | $ 0 |
Income Taxes (Details)
Income Taxes (Details) | 3 Months Ended | 6 Months Ended | |||
Jun. 30, 2024 USD ($) | Jun. 30, 2023 USD ($) | Jun. 30, 2024 USD ($) employee | Jun. 30, 2023 USD ($) | Dec. 31, 2023 USD ($) | |
Income Tax Disclosure [Abstract] | |||||
Income tax exemption, percentage | 90% | ||||
Minimum employee requirement | employee | 5 | ||||
Unrecognized tax benefit, interest and penalties accrued | $ 0 | $ 0 | $ 0 | ||
Income tax (benefit) expense | (1,000) | $ 16,000 | (15,000) | $ 51,000 | |
Net loss | $ 2,166,000 | $ 3,814,000 | $ 5,276,000 | $ 6,802,000 |
Earnings Per Share - Schedule o
Earnings Per Share - Schedule of Components of Diluted Earnings (Loss) Per Share (Details) - USD ($) $ / shares in Units, $ in Thousands | 3 Months Ended | 6 Months Ended | ||
Jun. 30, 2024 | Jun. 30, 2023 | Jun. 30, 2024 | Jun. 30, 2023 | |
Numerator | ||||
Net loss | $ (2,166) | $ (3,814) | $ (5,276) | $ (6,802) |
Gain of preferred stock transaction | 0 | 0 | 132,212 | 0 |
Numerator for earnings per share - net (loss) income attributable to common stockholders | $ (2,166) | $ (3,814) | $ 126,936 | $ (6,802) |
Denominator | ||||
Weighted average common stock outstanding – basic (in shares) | 2,554,512 | 3,000,895 | 2,554,512 | 3,011,011 |
Weighted average common stock outstanding – diluted (in shares) | 2,554,512 | 3,000,895 | 2,576,056 | 3,011,011 |
(Loss) income per share of common stock - Basic: | ||||
(Loss) income per basic common share (in USD per share) | $ (0.85) | $ (1.27) | $ 49.69 | $ (2.26) |
(Loss) income per share of common stock - Diluted: | ||||
(Loss) income per diluted common share (usd per share) | $ (0.85) | $ (1.27) | $ 49.28 | $ (2.26) |
Earnings Per Share - Additional
Earnings Per Share - Additional Information (Details) - $ / shares | Sep. 18, 2023 | Sep. 08, 2023 | Jun. 30, 2024 | Dec. 31, 2023 |
Earnings Per Share [Abstract] | ||||
Common stock, dividend rate approved | 70% | |||
Common stock, par value (in USD per share) | $ 0.01 | $ 0.01 | $ 0.01 | |
Dividends, number of additional shares issued per share owned (in shares) | 0.7 |
Earnings Per Share - Schedule_2
Earnings Per Share - Schedule of Antidilutive Securities Excluded From Computation of Earnings Per Share (Details) - shares | 3 Months Ended | 6 Months Ended | ||
Jun. 30, 2024 | Jun. 30, 2023 | Jun. 30, 2024 | Jun. 30, 2023 | |
Restricted stock | ||||
Denominator | ||||
Antidilutive shares excluded from computation of earnings per share (in shares) | 14,571 | 47,563 | 0 | 48,615 |
Preferred stock, if converted | ||||
Denominator | ||||
Antidilutive shares excluded from computation of earnings per share (in shares) | 0 | 115,370 | 0 | 115,370 |
Segment Information (Details)
Segment Information (Details) | 6 Months Ended |
Jun. 30, 2024 segment | |
Segment Reporting [Abstract] | |
Number of reportable segments | 2 |